 | |
Displaying braf melanoma PowerPoint Presentations
Vemurafenib: mechanisms of resistance and secondary skin ... PPT
Presentation Summary : Hersey P, et al. Targeting histone deacetylase to overcome resistance of BRAF V600E melanoma cells to apoptosis. J Clin Onc 29:2011. Abs 8516.
Source : http://hematology.wustl.edu/conferences/presentations/Knoche_2011-09-30.ppt
… Retrieve Document - St. Joseph Hospital of Orange ... PPT
Presentation Summary : Targeting Treatment to a Specific Variant in the Melanoma ... rate and prolongs survival in BRAF mutant metastatic melanoma patients Overcoming PLX 4032 ...
Source : http://www.sjo.org/documents/15.ppt
Personalized Cancer Medicine at Vanderbilt February 6, 2012 PPT
Presentation Summary : Tumor-Genome-Directed Anti-Cancer Therapy: Using Lung Cancer and Melanoma as a ParadigmNCI Workshop on “Next-Generation DNA Sequencing as a Tool for Clinical ...
Source : http://www.cancerdiagnosis.nci.nih.gov/pdf/meeting/Pao_William.pptx
Presentation Summary : ... Approved Guideline. * Accuracy, BRAF V600 Test Melanoma patients are given vemurafenib if tumor carries BRAF V600E mutation.
Source : http://www.cceb.upenn.edu/biostat/conferences/ClinTrials12/presentations/945UPennBiomarkerPennello20120418Final.ppt
Incident Melanoma in VISN 20: Findings from the rural ... PPT
Presentation Summary : INCIDENT MELANOMA IN VISN 20: ... V600E BRAF mutations (60% of all melanomas) * * Melanoma Overview – Treatment Costs Stage 0 - less than $5,000 Stage IV ...
Source : http://depts.washington.edu/dermatol/documents/T6_1_Bergman_Melanoma.ppt
NorCal - Society of Toxicology PPT
Presentation Summary : A375 (BRAF. V600E) xenograft. pERK. Ki67. Vehicle. 10 mg/kg. Growth Factors. RTKs. ... Modeling Resistance to RAF inhibitors in BRAF(V600E) Human Melanoma Xenografts ...
Source : http://www.toxicology.org/isot/rc/NorCal/docs/05_HOLASH_NorCalFallSymposium2012.pptx
Presentation Summary : 2002 BRAF mutations were discovered in Melanoma in 2003 found in WDTC, primarily PTC. Nucleotide 1799 --> Valine to Glutamate substitution ...
Source : http://www.uphs.upenn.edu/pennorl/education/documents/ResPresonThyroidCancer.ppt
Presentation Summary : FOCUS on Melanoma The leading national melanoma meeting REGISTER NOW! Venue: Wednesday 19th October, 2011 ... Response to ipilimumab was not influenced by BRAF status.
Source : http://www.skin-cancer-research-fund.org.uk/Focus%20on%20Melanoma%20Second%20Announcement%20160611.ppt
Genomics in Cancer Diagnosis – Quo Vadem? PPT
Presentation Summary : ... Ovary PTEN LOH/mutation hotspots mTOR inhibitors PI3KCA Exons 9 & 20 BRAF V600E/D/K/R/M Sorafenib/Braf inhibitors Melanoma BRAF V600E/D/K/R/M ...
Source : http://www.rcpath.org/Resources/MSPowerpoint/Dr%20G%20Vassiliou.ppt
Presentation Summary : PLX4032, a selective BRAF V600E inhibitor has shown substantial activity in BRAF mutated melanoma. This agent was investigated in 21 pts with mCRC.
Source : http://hematology.wustl.edu/conferences/presentations/Nagaraj_2011-04-29.ppt
Presentation Summary : ... Nature Cancer Review 2007 RAS Signaling Efficacy of trametinib (GSK1120212) in BRAF mutant melanoma and KRAS mutant NSCLC KRAS mutant NSCLC (n=14) 2 PR ...
Source : http://www.researchtopractice.com/sites/default/files/2012/HTML_Emails/WLCC/PPT/WLCC12_Keynote_Janne.ppt
Ras signaling - HGM2006 - Home PPT
Presentation Summary : ... Control Scr. B-RAF siRNA: Proliferation WM-266.4 cells: Melanoma cells with V600EB-RAF mutation WTB-RAF myc ... B-RAF G466V 1 V600E 480 BRaf V600E 0 ...
Source : http://hgm2006.hugo-international.org/Presentations/S6/HGM2006_S6_04_Marais.ppt
Presentation Summary : ... BRAF Inhibitor for Melanoma Targeting Mutations in Lung Cancer Slide 16 Signal Transduc-tion by HER family Trastuzumab improves survival for patients ...
Source : http://www.siteman.wustl.edu/uploadedFiles/Research_Programs/Educational_Opportunities/Cancer_Biology_Pathway/Introduction.2012b.ppt
What I Do Bryan Betz PhD - The University of Michigan - Welcome PPT
Presentation Summary : ... Clear Cell Sarcoma Microsatellite Instability Analysis KRAS Mutation BRAF V600E Mutation KIT Mutation in GIST KIT Mutation in Melanoma HER2 FISH, ...
Source : http://www.pathology.med.umich.edu/intra/Betz%20What%20I%20Do%20Talk.ppt
Metastatic Melanoma of Unknown Primary: A Unique Entity? PPT
Presentation Summary : BRAF: identified mutation in 66% of melanoma. Histiological Classification. Superficial Spreading: most common, arising in pre-existing nevus. Nodular: second most ...
Source : http://www.utmb.edu/otoref/Grnds/melanoma-unk-primary-2012-11-28/melanoma-unk-primary-pic-2012-11.pptx
Presentation Summary : A study of in Germany linked this trend to mutation of genes called BRAF 4% and CDKN2A 1%. Melanoma Incidence Incidence increases with age Graph thee ...
Source : http://web.cecs.pdx.edu/~mperkows/CLASS_479/lectures_2012_479/2011.%200009.%200-PPVIS_005A.%20Melanoma_Cancer.ppt
EandH CLRN Branded Powerpoint Presentation Slide Template Aug ... PPT
Presentation Summary : 9266 NCRN184 - GSK1120212 vs chemotherapy in adv or metastatic BRAF + melanoma. 9290 Energy expenditure in chronic kidney disease by indirect calorimetry.
Source : http://www.nepft.nhs.uk/_uploads/documents/RDdocs/nihrpresentation_281111.ppt
TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX PPT
Presentation Summary : Not recommended for use in patients with wild-type BRAF melanoma. Ivacaftor (Kalydeco)
Source : http://pec.ha.osd.mil/files/PECwebcast_Jun12_v2.pptx
Cell Signaling - ESMO - European Society for Medical Oncology ... PPT
Presentation Summary : ... CG CC Sample with no mutation Sample with mutation wildtype mutant wildtype mutant ABL1 AKT2 BRAF CDK4 EGFR ERBB2 FGFR1 ... % (0/164) Melanoma 8% (15 ...
Source : http://www.esmo.org/fileadmin/media/presentations/757/LCT17747878.ppt
FDA Device Panel Meeting Tanning Bed Classification PPT
Presentation Summary : My name is Suraj Venna and I am dermatologist and director of the melanoma center at the washington ... BRCA2, BRAF or MC1R. Phenotype - SPT I & II - Blue or Green eyes
Source : http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/GeneralandPlasticSurgeryDevicesPanel/UCM210424.pptx
Presentation Summary : Vultur, J. Villanueva and M. Herln, Targeting BRAF in Advanced Melanoma: A First Step toward Manageable Disease Clin Cancer Res April 1, 2011 17:1658 May 24, ...
Source : http://www.mbswonline.com/upload/presentation_5-26-2011-6-52-41.ppt
Integrating Molecular Pathology Services in the West Midlands PPT
Presentation Summary : ... be issued from 1st April 2010 BRAF analysis in colorectal cancer Pyrosequencing based assay BRAF and KIT in melanoma KIT mutated in non-skin melanomas ...
Source : http://cmgs.org/Restricted%20access%20area/CMGS%20members/CMGS%202010/Other/Other/JS4%20%20Integrating%20Molecular%20Pathology%20Services%20CMGS%202010%20J%20BELL.ppt
Introduction to cancer - YourGenome.org PPT
Presentation Summary : If these DNA changes occur in critical genes such as BRAF, ... Human melanoma cell undergoing cell division Credit: Paul Smith & Rachel Errington, ...
Source : http://www.yourgenome.org/downloads/pdf/teachers/kras/KRAS_cancer_pres.ppt
Roche Template - AAAS - The World's Largest General ... PPT
Presentation Summary : ... Patient #45 Day 15 Baseline Metastatic malignant melanoma Proper treatments – improper dose Gene test for CYP450-2D6, ... Her2, BRAF Case Report 5: ...
Source : http://www.aaas.org/spp/PM/ppts/Lindpainter.ppt
… Fetch Content - Research To Practice | An Integrated ... PPT
Presentation Summary : ... under development Combination therapy might hold best hope Adeno Squam Large Small KRAS Unknown EGFR HER2 BRAF ALK ... Melanoma (15% ...
Source : http://www.researchtopractice.com/sites/default/files/2011/Lung_Cancer/WLCC/ppt/WLCC2011_LynchKeynote.ppt
